Home

Innoviva, Inc.

CIK 1080014 · last filed 2023-01-12

Innoviva, Inc. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ARMP, was dated Jan 12, 2023. Across all open-market trades the lifetime net is +$199.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $141.7M across reported positions. The firm reports its address in Burlingame, CA. 64 SEC filings were submitted jointly with Michael W Aguiar.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$141.68M

Companies

2

Total Filings

9

Lifetime Open-Market Net

$199.13M

Filer Profile

Reported Address
1350 OLD BAYSHORE HIGHWAY
SUITE 400
BURLINGAME, CA 94010
Phone
(650) 238-9600
State of Incorporation
DE
Formerly Known As
THERAVANCE INC (2004–2015)
ADVANCED MEDICINE INC (2000–2000)
Related Filers
Michael W Aguiar — 64 joint filings, latest 2017-12-05
Bradford J Shafer — 53 joint filings, latest 2014-08-22
Mathai Mammen — 50 joint filings, latest 2014-08-22
David L Brinkley — 46 joint filings, latest 2013-05-31
Marianne Zhen — 46 joint filings, latest 2026-08-24
Rick E Winningham — 43 joint filings, latest 2014-08-19
Sarissa Capital Management LP — 39 joint filings, latest 2025-03-17
LEONARD M BLUM — 28 joint filings, latest 2014-08-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARMP Director 25,076,769 $5.65 $141.68M $140.01M 5 2023-01-12
Entasis Therapeutics Holdings Inc. (ETTX) Delisted 10%+ Owner 28,672,897 $2.19 $62.79M $59.12M 4 2022-02-23

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-01-12 ARMP Buy (P) — $0 EDGAR
2022-04-01 ARMP Buy (P) +10,770,416 $53.85M EDGAR
2022-02-23 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Other (J) — $0 EDGAR
2022-02-11 ARMP Buy (P) +7,229,584 $36.15M EDGAR
2021-05-20 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Buy (P) +7,462,050 $14.92M EDGAR
2021-03-17 ARMP Buy (P) +8,571,870 $27.86M EDGAR
2020-09-01 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Buy (P) +4,672,897 $12.50M EDGAR
2020-06-12 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Buy (P) +12,677,490 $31.69M EDGAR
2020-03-31 ARMP Buy (P) +7,717,661 $22.15M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.